Literature DB >> 1336726

Tumor-suppressor genes: cardinal factors in inherited predisposition to human cancers.

H J Evans1, J Prosser.   

Abstract

A predisposition to the development of certain specific and familial cancers is associated with the inheritance of a single mutated gene. In the best-characterized cases, this primary mutation is a loss of function mutation consistent with viability but resulting in neoplastic change consequent to the acquisition of a second somatic mutation at the same locus. Such genes are referred to as tumor-suppressor genes. Classical examples are the Rb-1 gene associated with the development of retinoblastoma and the p53 gene, which is associated with a wider range of neoplasms, including breast cancer. Other tumor-suppressor genes have been isolated which are associated with Wilms' tumor, neurofibromatosis, and inherited and sporadic forms of colorectal cancer. Some of these genes appear to act as negative regulators of mitotic cycle genes, and others may have different properties. The nature of these genes is discussed, as is the evidence for the involvement of tumor-suppressor genes in other inherited, and sporadic, forms of cancer. Some recent data on the Wilms' tumor gene, WT1, and on the involvement of the p53 gene in breast cancer are presented, and the importance of genomic imprinting in contributing to the excess of suppressor gene mutations in chromosomes of paternal origin is considered.

Entities:  

Mesh:

Year:  1992        PMID: 1336726      PMCID: PMC1519615          DOI: 10.1289/ehp.929825

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  168 in total

1.  Starting and stopping.

Authors:  G North
Journal:  Nature       Date:  1991-06-20       Impact factor: 49.962

2.  Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A.

Authors:  M Mudryj; S H Devoto; S W Hiebert; T Hunter; J Pines; J R Nevins
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

Review 3.  Rate-limiting steps: the genetics of pediatric cancers.

Authors:  D A Haber; D E Housman
Journal:  Cell       Date:  1991-01-11       Impact factor: 41.582

4.  Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product.

Authors:  D Defeo-Jones; P S Huang; R E Jones; K M Haskell; G A Vuocolo; M G Hanobik; H E Huber; A Oliff
Journal:  Nature       Date:  1991-07-18       Impact factor: 49.962

5.  Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers.

Authors:  K W Kinzler; M C Nilbert; B Vogelstein; T M Bryan; D B Levy; K J Smith; A C Preisinger; S R Hamilton; P Hedge; A Markham
Journal:  Science       Date:  1991-03-15       Impact factor: 47.728

6.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

7.  The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F.

Authors:  S Bagchi; R Weinmann; P Raychaudhuri
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

8.  Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis.

Authors:  M Miyaki; M Seki; M Okamoto; A Yamanaka; Y Maeda; K Tanaka; R Kikuchi; T Iwama; T Ikeuchi; A Tonomura
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

9.  Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis.

Authors:  C Coles; A M Thompson; P A Elder; B B Cohen; I M Mackenzie; G Cranston; U Chetty; J Mackay; M Macdonald; Y Nakamura
Journal:  Lancet       Date:  1990-09-29       Impact factor: 79.321

10.  Increased expression of mutant forms of p53 oncogene in primary lung cancer.

Authors:  R Iggo; K Gatter; J Bartek; D Lane; A L Harris
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

View more
  3 in total

1.  Expression of cell cycle regulatory proteins (p53, pRb) in the human female genital tract.

Authors:  A Bukovsky; M R Caudle; J A Keenan; J Wimalasena; J S Foster; N B Upadhyaya; S E van Meter
Journal:  J Assist Reprod Genet       Date:  1995-02       Impact factor: 3.412

2.  Loss of heterozygosity of chromosome 13q33-34 region and molecular analysis of ING1 and p53 genes in bladder carcinoma.

Authors:  Mehri Igci; Ahmet Arslan; Sakip Erturhan; Yusuf Ziya Igci; Elif Pala; Bulent Gogebakan; Metin Karakok; Ecir Ali Cakmak; Beyhan Cengiz
Journal:  Mol Biol Rep       Date:  2014-10-17       Impact factor: 2.316

3.  Cantharidin alters the expression of genes associated with the NKG2D-associated immune response in TSGH-8301 human bladder carcinoma cells.

Authors:  Jehn-Hwa Kuo; An-Cheng Huang; Jen-Jyh Lin; Kuang-Chi Lai; Rick Sai-Chuen Wu; Jiun-Long Yang; Bin-Chuan Ji; Mei-Due Yang; Yung-Lin Chu; Jing-Gung Chung
Journal:  Oncol Lett       Date:  2017-05-12       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.